The test will enable physicians to assess if post-surgery cancer patients need to receive treatment to minimize the risk of ...

The deal gives Boston Scientific a 34% equity stake in MiRus and an option to acquire its TAVR platform by making additional ...

Embecta closed its acquisition of Owen Mumford Holdings on Friday, shifting its focus from diabetes products to broader ...

The decision to wind down the operation in Santa Rosa in about two years comes as the medtech giant combines several ...

The Labcorp agreement continues the expansion of Aura, which gives healthcare providers access to tests from companies ...

A weak investment climate in the Americas contributed to declines in the German company’s intraocular lens business in the ...

PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...

The company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.

Created by Johns Hopkins University researchers, the early warning system for sepsis aims to help physicians detect the ...

The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device. Tandem Diabetes Care ...

With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.

Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with ...